| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |